Could sleep boost waste disposal in the brain and prevent Parkinson’s?
Date
Research news
New research on levodopa's influence on Parkinson's progression
Date
A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.
Steps towards new drugs to improve symptoms and slow Parkinson’s
Date
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
Scientists use gene editing to create 'tougher' stem cells
Date
Researchers at the University of Edinburgh have used cutting-edge gene-editing techniques to create stem cells that are resistant to developing Parkinson’s.
We're changing the way we review our project grant applications
Date
We're streamlining and speeding up our project grant review process.
Experimental cancer drug shows promise for Parkinson's
Date
A drug originally developed for prostate cancer may have exciting potential for treating Parkinson's, according to research published today in Cell Stem Cell.
People who smoke may be less likely to develop Parkinson's
Date
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Stopping the build-up of toxic proteins in Parkinson's
Date
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
Research points to the appendix being the source of Parkinson's
Date
Results published today in the scientific journal Science Translational Medicine highlights a link between the removal of the appendix and a reduced risk of developing Parkinson's.
10,000 people without Parkinson's needed for online study
Date
The UK-wide Predict PD study, funded by Parkinson's UK, is seeking 10,000 people aged 60-80 without Parkinson's to find clues to the very earliest stages of the condition.
Promising early results for potential new treatment for Parkinson's
Date
The pharmaceutical company Biogen has presented promising initial results from trials testing a potential new treatment for Parkinson's which targets the alpha-synuclein protein.